Filtros de búsqueda

Lista de obras de Markolf Hanefeld

"Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice

artículo científico publicado en 2009

35th Annual Meeting of the European Association for the Study of Diabetes

artículo científico

35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999

article

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial

artículo científico publicado en 2005

A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes

artículo científico publicado en 2014

A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes

artículo científico publicado en 2006

A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus.

artículo científico publicado en 2017

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

artículo científico publicado en 2002

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

artículo científico publicado en 2004

Acarbose revisited for efficacy, safety and cardiovascular benefits: a key role for controlling glycemic variability

scientific article published on 01 July 2012

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance

artículo científico publicado en 2004

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

artículo científico publicado en 2003

Acarbose: oral anti-diabetes drug with additional cardiovascular benefits

artículo científico publicado en 2008

Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis

artículo científico publicado en 2004

Alpha-glucosidase inhibitors for patients with type 2 diabetes: response to van de Laar et al

artículo científico publicado en 2005

An update on preventive and regenerative therapies in diabetes mellitus

scientific article published on 25 December 2008

Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I.

artículo científico publicado en 1997

Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study

artículo científico publicado en 2007

Association of physical activity with insulin resistance, subclinical inflammation, coagulation, and fibrinolytic biomarkers among population at high risk for type 2 diabetes

artículo científico publicado en 2012

Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies

artículo científico publicado en 2013

Association of the calpain-10 gene with type 2 diabetes in Europeans: Results of pooled and meta-analyses

article

Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial

artículo científico publicado en 2014

Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)

artículo científico publicado en 2014

Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial

artículo científico publicado en 2016

Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review

artículo científico publicado en 2013

Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes

artículo científico publicado en 2007

Challenge in diabetes therapy: effects of glitazones beyond blood glucose control

artículo científico publicado en 2009

Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients

artículo científico publicado en 2009

Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114.

artículo científico publicado en 2016

Conversion of IGT to type 2 diabetes mellitus is associated with incident cases of hypertension: a post-hoc analysis of the STOP-NIDDM trial

artículo científico publicado en 2012

Coronary heart diseases and associated risk factors in newly manifested type II diabetic patients over the course of 5 years

artículo científico publicado en 1989

Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol

artículo científico publicado en 2019

Dapagliflozin, an SGLT2 inhibitor, for diabetes

artículo científico publicado en 2010

Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide

artículo científico publicado en 2017

Determinants of mortality in patients with type 2 diabetes: a review

artículo científico publicado en 2016

Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM.

artículo científico publicado en 1991

Differences in Glycemic Variability Between Normoglycemic and Prediabetic Subjects

artículo científico publicado en 2014

Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays--an evaluation with samples from the PIOstat study.

artículo científico publicado en 2009

Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes

artículo científico publicado en 2002

Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies

artículo científico publicado en 2010

Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therap

artículo científico publicado en 2011

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

artículo científico publicado en 2019

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

artículo científico publicado en 2019

Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials

artículo científico publicado en 2016

Effect of acarbose on postmeal mononuclear blood cell response in patients with early type 2 diabetes: the AI(I)DA study

artículo científico publicado en 2009

Effect of acarbose on vascular disease in patients with abnormal glucose tolerance

artículo científico publicado en 2008

Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).

artículo científico publicado en 2013

Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study

artículo científico publicado en 2011

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

artículo científico publicado en 2006

Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study

artículo científico publicado en 2007

Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes

artículo científico publicado en 2010

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).

artículo científico publicado en 2008

Effect of weight reduction on carbohydrate and fatty-acid metabolism in obese, maturity-onset diabetic patients

artículo científico publicado el 15 de mayo de 1975

Effects of high doses of oestrogens and androgens on lipoproteins: observations in the treatment of excessive growth with sexual hormones.

artículo científico publicado en 1985

Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes

artículo científico publicado en 2013

Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study

artículo científico publicado en 2008

Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetes

artículo científico publicado en 2008

Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study

artículo científico publicado en 2014

Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospective, randomized, double-blind, three-parallel arm, multic

artículo científico

Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study

artículo científico publicado en 2011

Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment

artículo científico publicado en 2017

Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal-F1).

artículo científico publicado en 2013

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial

artículo científico publicado en 2004

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

artículo científico publicado en 2006

Elevated fasting glucose levels predicts IGT and diabetes also in middle-age subjects

artículo científico publicado en 2006

Elimination of lipofundin S during the intravenous fat tolerance test in patients with low, medium, and high fasting triglyceride concentrations

artículo científico publicado en 1985

Erratum to: Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.

artículo científico publicado en 2010

Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Tri

artículo científico publicado en 2017

Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care research

artículo científico publicado en 2008

Fat-cell volume in maturity-onset diabetes.

artículo científico publicado en 1971

Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening

artículo científico publicado en 2004

Free fatty acids in microsamples of capillary blood: fasting levels, progress curves and daily profiles

artículo científico publicado en 1972

Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis

artículo científico publicado en 2007

Glycemic control and cardiovascular benefit: What do we know today?

artículo científico publicado en 2010

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.

artículo científico publicado en 2010

High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone

artículo científico publicado en 2010

Human adipocyte volumes: maximum size, and correlation to weight index in maturity onset-diabetes

artículo científico publicado en 1972

Hyperinsulinemia in patients with low fractional catabolic rate of triglycerides.

artículo científico publicado en 1981

Hyperlipidemia and fibrates with special reference to diabetes

artículo científico publicado en 2001

Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter

artículo científico publicado en 2006

Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies

artículo científico

Hypoglycemia and Cardiovascular Risk: Is There a Major Link?

artículo científico publicado en 2016

Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human genetics

artículo científico publicado en 2009

Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type II diabetes and control subjects

artículo científico publicado en 1996

Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus

artículo científico publicado en 2005

Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women

artículo científico publicado en 1994

Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study

artículo científico publicado en 2007

Impaired fasting glucose is not a risk factor for atherosclerosis

artículo científico publicado en 1999

Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism

artículo científico publicado en 2000

Impaired glucose tolerance is not associated with lipid intolerance

artículo científico publicado en 2002

In high risk for diabetes should drugs be used for prevention? (interview by Dr. Judith Neumaier)

artículo científico publicado en 2002

In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control

artículo científico publicado en 2004

In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance

artículo científico publicado en 1998

In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance

artículo científico publicado en 2002

Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study

artículo científico publicado en 2011

Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors

artículo científico publicado en 1999

Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitus

artículo científico publicado en 2016

Influence of diet composition on insulin output, carbohydrate tolerance and lipid values in primary hypertriglyceridemia (HT)

artículo científico publicado el 1 de marzo de 1978

Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients

artículo científico publicado en 2003

Insulin and atherosclerosis: how are they related?

artículo científico

Insulin resistance and metabolic parameters in type 2 diabetic patients.

artículo científico publicado en 2002

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study

artículo científico publicado en 2003

Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trial

artículo científico publicado en 2013

Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass

artículo científico publicado en 2002

Intensive basic therapy decreases the need for drug treatment and improves glucose control: an important result of the diabetes intervention study

artículo científico publicado en 1988

Interpretation of oral glucose tolerance tests

artículo científico publicado en 2009

Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes

artículo científico publicado en 2017

Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol

artículo científico publicado en 2017

Introduction: new approaches to managing diabetic dyslipidaemia

scientific article published on 01 September 2005

Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk

artículo científico publicado en 2008

Is hyperglycemia a cardiovascular risk factor?

artículo científico publicado en 2011

Is rosiglitazone associated with increased risk for cardiovascular events?

scientific article published on 09 October 2007

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

artículo científico publicado en 2010

Is the newly suggested fasting plasma glucose cut-off point for the diagnosis of diabetes the right one?

artículo científico publicado en 1999

Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes

artículo científico publicado en 2002

Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trials

artículo científico publicado en 2014

Long-Term Effect of Octreotide in Acromegaly on Insulin Resistance ⬇️

artículo científico publicado el 1 de mayo de 1995

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

artículo científico publicado en 2005

Loss of fat, water, and protein during very low calorie diets and complete starvation

artículo científico publicado en 1987

Metabolic Vascular Syndrome: New Insights into a Multidimensional Network of Risk Factors and Diseases

artículo científico publicado en 2016

Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial

artículo científico publicado en 2009

Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia

artículo científico publicado en 2008

Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes

artículo científico publicado en 2007

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes

artículo científico publicado en 2004

Oral glucose tolerance test: to be or not to be performed?

artículo científico publicado en 2002

Physical activity is strongly inversely related to post-challenge plasma glucose and glycemic spikes in a risk population for type 2 diabetes

artículo científico publicado en 2013

Polymorphisms in perilipin gene (PLIN) are not associated with obesity and weight variation in people with high risk of type 2 diabetes

artículo científico publicado en 2008

Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes

artículo científico publicado en 2000

Postprandial glucose regulation and diabetic complications

artículo científico publicado en 2004

Postprandial glucose regulation: new data and new implications

artículo científico publicado en 2005

Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update

artículo científico publicado en 2006

Postprandial hyperglycaemia: noxious effects on the vessel wall

artículo científico publicado en 2002

Postprandial hyperglycemia as a risk factor for cardiovascular disease. Therapy improves prognosis

artículo científico publicado en 2004

Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals

artículo científico publicado en 1999

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

artículo científico publicado en 2016

Prandial hyperglycemia: is it important to track and treat?

artículo científico publicado en 2005

Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy

artículo científico publicado en 2006

Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study

artículo científico publicado en 2002

Predictors of response to early basal insulin treatment in patients with type 2 diabetes--the EARLY experience

artículo científico publicado en 2013

Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?

artículo científico publicado en 2000

Prevalence of diabetes-specific autoantibodies in patients at risk for adult onset diabetes mellitus

artículo científico publicado en 1998

Pulse pressure is a strong predictor of cardiovascular risk: Data of the risk factors in impaired glucose tolerance for atherosclerosis and diabetes and the Sofia Metabolic Syndrome studies.

artículo científico publicado en 2009

Rational therapy of Type II diabetes

artículo científico publicado en 1996

Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update

scientific article published on 20 June 2020

Relation of free and specifically bound leptin to insulin secretion in patients with impaired glucose tolerance (IGT).

artículo científico publicado en 1999

Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients

artículo científico publicado en 2007

Relationship between diurnal glucose levels and HbA1c in type 2 diabetes

artículo científico publicado en 2006

Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals

artículo científico publicado en 1998

Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias

scientific article published on 16 September 2013

Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for "late-onset" hypogonadism: A case report

artículo científico publicado en 2019

Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study

artículo científico publicado en 2020

Results of protein-sparing modified fasting in hyperlipoproteinemias

artículo científico publicado en 1985

Review of approved pioglitazone combinations for type 2 diabetes

artículo científico publicado en 2011

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

artículo científico publicado en 1996

Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions

artículo científico publicado en 2015

Rosiglitazone RECORD study: glucose control outcomes at 18 months

artículo científico publicado en 2007

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

artículo científico publicado en 2009

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

artículo científico publicado en 2007

Screening, prevention and early therapy of type 2 diabetics

artículo científico publicado en 2004

Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trials

artículo científico publicado en 2014

Serum and Plasma Levels of Vascular Endothelial Growth Factors in Relation to Quality of Glucose Control, Biomarkers of Inflammation, and Diabetic Nephropathy

artículo científico publicado en 2016

Shifting the disease management paradigm from glucose: what are the cons?

artículo científico publicado en 2009

Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?

artículo científico publicado en 2012

Significance of triglycerides for other metabolic parameters in the familial metabolic syndrome

artículo científico publicado el 19 de septiembre de 2003

Structured health care for subjects with diabetic foot ulcers results in a reduction of major amputation rates

artículo científico publicado en 2013

Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes

artículo científico publicado en 2002

Sudomotor Testing of Diabetes Polyneuropathy

The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles.

artículo científico publicado en 2009

The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes: Response to Kilpatrick et al

article

The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes

artículo científico publicado en 2008

The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale

artículo científico publicado en 2020

The anorexigenic peptide neurotensin relates to insulin sensitivity in obese patients after BPD or RYGB metabolic surgery

artículo científico publicado en 2018

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, dou

artículo científico publicado en 2008

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

artículo científico publicado en 2020

The future of the metabolic syndrome

artículo científico publicado en 2009

The metabolic syndrome and cardiovascular disease - an ongoing tsunami

artículo científico publicado en 2013

The metabolic syndrome and its epidemiologic dimensions in historical perspective

artículo científico publicado en 2002

The metabolic vascular syndrome - guide to an individualized treatment

artículo científico publicado en 2016

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes

artículo científico publicado en 2013

The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL.

artículo científico publicado en 2017

Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes

artículo científico publicado en 2003

To: Strey CH, Young J, Collier M, Florkowski CM, Shand BI, Scott RS (2004) The postprandial state does not impair endothelial function in women with Type 2 diabetes irrespective of glycaemic control. Diabetologia 47:1838-1846.

artículo científico publicado en 2005

Treatment of impaired glucose tolerance with acarbose and its effect on intima-media thickness: a substudy of the STOP-NIDDM trial (study to prevent non-insulin-dependent diabetes mellitus).

artículo científico publicado en 2006

Urinary tract infection in patients with diabetes mellitus.

artículo científico publicado en 2012

Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study

artículo científico publicado en 2007

Work absenteeism in type 2 diabetes mellitus: results of the prospective Diabetes Intervention Study

artículo científico publicado en 1993

[Liver findings in primary hyperlipoproteinemia (HLP)]

artículo científico publicado en 1973

[Metabolic syndrome: "common soil" for diabetes and atherosclerosis. Novel approaches to an integrated therapy]

artículo científico publicado en 2006

[Multimodal therapy of dyslipidemia]

scientific article published on 01 May 2011

[Presentation of an insulin-treated patient group within the scope of a 5-year study of the Diabetes Intervention Study (DIS)]

artículo científico publicado en 1987

40 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004 ⬇️

artículo

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda